Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

It achieves high fluorescence resonance energy transfer contrast and enables tuning of the response window for improved sensor specificity, multiplexing and logic sensing. This study presents P ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Masimo (NASDAQ:MASI) Corporation (NASDAQ:MASI), a medical technology company, has announced the termination of its Chief Executive Officer, Joe Kiani, effective October 24, 2024. The decision was ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Masimo has filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of illegally manipulating a recent shareholder vote. The suit, filed in ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

The EMS1 Pulse Oximeters product category features products and information for researching EMS pulse oximeters, covering a variety of CO testing equipment, patient monitoring devices, and other ...

A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an award of just $250 for the tech giant | Despite the victory, Masimo says the ruling does not ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...